|
|
Volumn 31, Issue 3, 2013, Pages 399-
|
|
Erratum: Randomized Phase II Study of Dacomitinib (PF-00299804), an Irreversible Pan-Human Epidermal Growth Factor Receptor Inhibitor, Versus Erlotinib in Patients With Advanced Non-Small-Cell Lung Cancer (Journal of Clinical Oncology (2012) 30 (3337-3344))
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ERRATUM;
ERROR;
PRIORITY JOURNAL;
|
|
EID: 84873384213
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2012.48.4790 Document Type: Erratum |
|
Times cited : (2)
|
|
References (0)
|